Evidence map›Paper›PMID 39955527›Full record

ArticleHarm reduction journal2025

Utilization of drug checking services in Austria: a cross-sectional online survey.

Alexandra Karden, Tobias Fragner, Cornelia Feichtinger, Julian Strizek, Daragh T McDermott, Igor Grabovac

Abstract read
In one paragraph

Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandra KardenSuchthilfe Wien gGmbH (Vienna Addiction Services), Gumpendorfer Gürtel 8, Vienna, 1060, Austria.
Tobias FragnerDepartment of Social and Preventive Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria. tobias.fragner@meduniwien.ac.at.
Cornelia FeichtingerDepartment of Social and Preventive Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria.
Julian StrizekGesundheit Österreich GmbH (Austrian Public Health Institute), Stubenring 6, Vienna, 1010, Austria.
Daragh T McDermottSchool of Social Sciences, Nottingham Trent University, 50 Shakespeare Street, Nottingham, NG14BU, UK.
Igor GrabovacDepartment of Social and Preventive Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of psychoactive substances is a key public health issue due to its impact on mental, physical, and social health. Integrated drug checking is a well-known harm reduction and addiction prevention measure and is currently implemented in four federal states in Austria. The aim of this study is to investigate the prevalence of drug checking use among a web-survey sample of people who use drugs (PWUD) in Austria and to examine differences in socio-demographic and substance use characteristics between individuals with and without drug checking experience. In addition, reasons for not using these services are explored.

methodsA secondary data analysis of the Austrian data from the European Web Survey on Drugs (EWSD), a targeted survey conducted between March and May 2021 was performed. Based on reported drug checking experience, the data set was divided into two groups - those with and without drug checking experience - and compared.

resultsIn this web-survey sample of PWUD (n = 1113), 20.1% reported prior use of a drug checking service in Austria. The groups with drug checking experience (n = 224) and those without (n = 889) differed significantly in both univariate and multivariate analyses. Univariate analysis revealed significant differences in terms of age, household composition, highest level of education, employment status, region of residence, substance use prevalences and treatment experience. Participants who used cannabis only had significantly less experience with drug checking. No significant differences were found regarding gender and income. While logistic regression analysis showed a significant relationship between sociodemographic predictors and drug checking experience, this relationship was relatively weak. The main reasons for not having used the services yet included a high level of trust in the source of supply (68%), confidence in receiving high quality of substances (64%), and a lack of service availability near the place of residence (62%).

conclusionsThe results indicate that drug checking services are well-accepted and trusted but not equally accessed by and accessible to all PWUD. Specifically, people who use only cannabis and those residing with parents or in rural or small-town areas access services less. In conclusion, there is considerable potential for expanding the availability and accessibility of drug checking services in Austria, particularly to reach underserved groups of PWUD who could benefit from this intervention.

Indexed as

Drug UsersSubstance-Related DisordersAdolescentAdultAustriaCross-Sectional StudiesFemaleHarm ReductionHumansInternetMaleMiddle AgedSurveys and QuestionnairesYoung AdultAddiction preventionDrug checkingHarm reductionPublic healthPWUD

Identifiers

PMID39955527
PMCPMC11829356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.